公司简介

Neurotrope BioScience, (NASDAQ:NTRP), formed in 2012, is at the forefront of the biotech industry and is focused on developing new therapies with Bryostatin 1 for the treatment of neurodegenerative diseases and developmental disorders.

主要成员

Anton C. Krucky、Thomas F. Cannon

产品/服务

• 药物基因组
• DTC基因检测

Bryostatin 1

Orphan Drug。

Alzheimer's Disease

Fragile X syndrome

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2013-09	未披露	$21.9M

关联公司